The India MedTech Expo 2025 concluded at Bharat Mandapam, Pragati Maidan, New Delhi, showcasing India’s rapid strides in the medical devices and MedTech sector. Organized by the Department of Pharmaceuticals (DoP) under the Ministry of Chemicals & Fertilizers, the three-day event brought together global stakeholders, policymakers, and innovators, reinforcing India’s position as a hub for precision-driven yet affordable MedTech solutions.
India’s Medical Devices Growth Story
Highlighting India’s progress, Shri Amit Agrawal, Secretary, Department of Pharmaceuticals, noted that:
-
The domestic share of medical devices has increased from 10% to 30% over the last five years.
-
Even in high-end Class C devices, India now contributes 20% of domestic needs.
-
Exports have crossed $4 billion in the same period.
“India has made a quantum jump in MedTech manufacturing. From Class A and B non-invasive devices two years ago, global buyers are now keen on Class C invasive products where we are already 10–40% cheaper than global competitors,” Shri Agrawal said.
Global Interest and Collaboration
This year’s edition witnessed participation from 500+ domestic companies and 150 international buyers from over 30 countries. Thousands of foreign delegates showed keen interest in India’s affordable Class C devices.
In a notable development, Algeria expressed interest in working with India to harmonize regulatory approvals, creating new opportunities for Indian manufacturers. Prof. Salah Derradji, Algerian regulator, stated:
“Algeria produces only 2% of its medical device requirements. Indian companies can fill this huge gap if they step up marketing and visibility.”
Key Government Commitments
-
Capacity Building:
Ms. Gayatri Nair, Economic Advisor, DoP, said:
“Capacity-building programs, both short and long term, have been rolled out. Within a year, trained technical experts will strengthen the MedTech ecosystem.” -
Data and Regulation:
Ms. Sai Ahlladini Panda, Member Secretary, NPPA, emphasized the need for improved clinical and quality data, crucial for advancing device standards. -
Regulatory Growth:
Shri Aseem Sahu, Deputy Drug Controller, CDSCO, underlined that manufacturers have grown from 400 to 4,000 in just five years, reflecting regulatory evolution. -
Raising Standards:
Shri Hitendra Sahu, Director, DoP, stressed the need to raise testing benchmarks to match global quality and multiply exports.
Expo Highlights
Themed “India: Global MedTech Manufacturing Hub, Precision Engineering yet Affordable”, the expo featured:
-
Exhibitions: Showcasing MSMEs, start-ups, state government pavilions, and research institutions.
-
Conferences & CEO Roundtables: Engaging discussions on innovation, regulatory frameworks, and investment opportunities.
-
Experience Zones & Networking: B2B meetings, Reverse Buyer-Seller Meets, and regulator open houses.
Supported by major industry associations including AIMED, MTAI, AMTZ, ASSOCHAM, CII, FICCI, USIBC, and USISPF, the expo successfully created a platform for collaboration across the MedTech value chain.
Looking Ahead
The Indian MedTech sector is one of the fastest-growing healthcare segments. With government support, rising global demand, and strong domestic capabilities, India is well on its way to becoming a global MedTech manufacturing powerhouse.
As Shri Agrawal concluded, “The journey towards an Atmanirbhar MedTech ecosystem has begun. With innovation, partnerships, and global collaboration, India is ready to lead.”
